This cutting-edge clinical reference presents the latest findings and procedures concerning the diagnosis, treatment, management, and prognosis of renal, bladder, prostate and testicular cancer. Leading international authorities deal with the full range of clinical issues of paramount importance in oncological urology. They cover testicular cancer, renal cell and transitional cell carcinoma, new applications of cytokines, molecular markers, early diagnosis, characteristics of prostate cancer in different prostate-specific antigen ranges, the accuracy of biopsy information in determining outcome, laparoscopic radical prostatectomy, watchful waiting versus early endocrine treatment in "low risk" prostate cancer, biochemical outcome after radical prostatectomy, external beam radiation therapy or interstitial radiation therapy for clinically localized prostate cancer, screening for prostate cancer, chemo-endocrine prevention, the molecular mechanisms of hormone resistance in prostate cancer, early versus delayed endocrine therapy, antiandrogen monotherapy, intermittent androgen suppression, adjuvant and neoadjuvant treatment of prostate cancer, gene therapy in urology, non-endocrine systemic approaches for prostate cancer, novel detection strategies for transitional cell carcinoma, aminolevulinic acid induced fluorescence endoscopy (AFE) for detection of lower urinary tract tumors, Ta-T1 G1-2 transitional cell-carcinoma, BCG in transitional cell carcinoma, high-grade transitional cell carcinoma, brachytherapy for transitional cell carcinoma of the bladder, and systemic treatment in locally advanced and metastatic bladder cancer. Includes bibliographic references and index.